Cartesian Therapeutics

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$947
$452
$298
$1,100
Gross Profit
947
-12,345
298
1,100
EBITDA
-21,939
-35,296
16,475
-20,733
EBIT
-35,902
15,886
-21,889
Net Income
-92,576
-35,902
15,886
-17,710
Net Change In Cash
947
452
298
1,100
Free Cash Flow
-18,204
-16,892
-20,116
-24,183
Cash
125,139
143,384
160,324
180,434
Basic Shares
25,973
26,002
26,447
25,902

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,797
$38,913
$26,004
$110,777
Gross Profit
2,797
38,913
26,004
108,740
EBITDA
-86,705
-75,986
-235,034
39,838
EBIT
-77,137
-235,877
37,801
Net Income
-130,302
-77,424
-219,710
35,379
Net Change In Cash
2,797
38,913
26,004
110,777
Cost of Revenue
-7,418
Free Cash Flow
-79,395
-32,767
-51,367
-32,832
Cash
125,139
212,610
76,911
106,438
Basic Shares
25,973
23,689
5,170
4,052

Earnings Calls

QuarterEPS
2025-12-31
-$2.70
2025-09-30
-$1.38
2025-06-30
-$0.77
2025-03-31
-$0.65